Brief: Addex Says Dipraglurant Restores Synaptic Plasticity In Two Models Of Dystonia

Addex Therapeutics

17/05/2021 06:05

May 17 (Reuters) - ADDEX THERAPEUTICS LTD  ADXN.S :
    * DIPRAGLURANT WAS ABLE TO RESCUE LONG-TERM IMPAIRMENT OF
SYNAPTIC
PLASTICITY IN TWO WELL VALIDATED MODELS OF DYSTONIA
    * A PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL OF
DIPRAGLURANT IN
BLEPHAROSPASM PATIENTS IS SCHEDULED TO BEGIN DURING Q2 2021

Source text for Eikon:  ID:nGNE5sCLpQ 
Further company coverage:  ADXN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))